Phrixus

1 stories · following the connections

Business

FDA allows Phrixus’s IND for Carmeseal-MD™ (P-188 NF) in Duchenne muscular dystrophy (DMD)

By Nasdaq OMXSep 7, 2016, 12:00 PM UTC